Cargando…

Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma

The surgical management of papillary thyroid microcarcinoma (PTMC), especially regarding the necessity of central/lateral lymph node dissection, remains controversial. This study investigated the clinicopathologic factors predictive of lymph node metastasis (LNM) in patients diagnosed with PTMC. Mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Dao-zhe, Qu, Ning, Shi, Rong-liang, Lu, Zhong-wu, Ji, Qing-hai, Wu, Wei-li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004998/
https://www.ncbi.nlm.nih.gov/pubmed/27601922
http://dx.doi.org/10.2147/OTT.S107913
_version_ 1782450846494097408
author Lin, Dao-zhe
Qu, Ning
Shi, Rong-liang
Lu, Zhong-wu
Ji, Qing-hai
Wu, Wei-li
author_facet Lin, Dao-zhe
Qu, Ning
Shi, Rong-liang
Lu, Zhong-wu
Ji, Qing-hai
Wu, Wei-li
author_sort Lin, Dao-zhe
collection PubMed
description The surgical management of papillary thyroid microcarcinoma (PTMC), especially regarding the necessity of central/lateral lymph node dissection, remains controversial. This study investigated the clinicopathologic factors predictive of lymph node metastasis (LNM) in patients diagnosed with PTMC. Multivariate logistic regression analysis was used for PTMC patients identified from the Surveillance, Epidemiology, and End Results database who were treated by surgery between 2002 and 2012, to determine the association of clinicopathologic factors with LNM. According to the results, a total of 31,017 patients met the inclusion criteria of the study. Final histology confirmed 2,135 (6.9%) cases of N1a disease and 1,684 cases (5.4%) of N1b disease. Our multivariate logistic regression analysis identified variables associated with both central LNM and lateral lymph node metastasis (LLNM), including a younger age (<45 years), male sex, non-Hispanic white and other race, classical papillary histology, larger tumor size, multifocality, and extrathyroidal extension; distant metastasis was also significantly associated with LLNM. The significant predictors identified from multivariable logistic regression were integrated into a statistical model that showed that extrathyroidal extension had maximum weight in the predictive role for LNM. LLNM was validated to be a significant risk factor for cancer-specific death in Cox regression analyses, whereas central LNM failed to predict a worse cancer-specific survival according to our data. Therefore, we suggested that central lymph node dissection could be performed in certain patients with risk factors. Given the prevalence of LLNM in PTMC, a thorough inspection of the lateral compartment is recommended in PTMC patients with risk factors for precise staging; from the viewpoint of a radical treatment for tumors, prophylactic lateral lymph node dissection that aims to remove the occult lateral lymph nodes may be an option for PTMC with risk factors. Multicenter studies with long-term follow-up are recommended to better understand the risk factors and surgical management for cervical nodes in PTMC.
format Online
Article
Text
id pubmed-5004998
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-50049982016-09-06 Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma Lin, Dao-zhe Qu, Ning Shi, Rong-liang Lu, Zhong-wu Ji, Qing-hai Wu, Wei-li Onco Targets Ther Original Research The surgical management of papillary thyroid microcarcinoma (PTMC), especially regarding the necessity of central/lateral lymph node dissection, remains controversial. This study investigated the clinicopathologic factors predictive of lymph node metastasis (LNM) in patients diagnosed with PTMC. Multivariate logistic regression analysis was used for PTMC patients identified from the Surveillance, Epidemiology, and End Results database who were treated by surgery between 2002 and 2012, to determine the association of clinicopathologic factors with LNM. According to the results, a total of 31,017 patients met the inclusion criteria of the study. Final histology confirmed 2,135 (6.9%) cases of N1a disease and 1,684 cases (5.4%) of N1b disease. Our multivariate logistic regression analysis identified variables associated with both central LNM and lateral lymph node metastasis (LLNM), including a younger age (<45 years), male sex, non-Hispanic white and other race, classical papillary histology, larger tumor size, multifocality, and extrathyroidal extension; distant metastasis was also significantly associated with LLNM. The significant predictors identified from multivariable logistic regression were integrated into a statistical model that showed that extrathyroidal extension had maximum weight in the predictive role for LNM. LLNM was validated to be a significant risk factor for cancer-specific death in Cox regression analyses, whereas central LNM failed to predict a worse cancer-specific survival according to our data. Therefore, we suggested that central lymph node dissection could be performed in certain patients with risk factors. Given the prevalence of LLNM in PTMC, a thorough inspection of the lateral compartment is recommended in PTMC patients with risk factors for precise staging; from the viewpoint of a radical treatment for tumors, prophylactic lateral lymph node dissection that aims to remove the occult lateral lymph nodes may be an option for PTMC with risk factors. Multicenter studies with long-term follow-up are recommended to better understand the risk factors and surgical management for cervical nodes in PTMC. Dove Medical Press 2016-08-24 /pmc/articles/PMC5004998/ /pubmed/27601922 http://dx.doi.org/10.2147/OTT.S107913 Text en © 2016 Lin et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Lin, Dao-zhe
Qu, Ning
Shi, Rong-liang
Lu, Zhong-wu
Ji, Qing-hai
Wu, Wei-li
Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma
title Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma
title_full Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma
title_fullStr Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma
title_full_unstemmed Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma
title_short Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma
title_sort risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004998/
https://www.ncbi.nlm.nih.gov/pubmed/27601922
http://dx.doi.org/10.2147/OTT.S107913
work_keys_str_mv AT lindaozhe riskpredictionandclinicalmodelbuildingforlymphnodemetastasisinpapillarythyroidmicrocarcinoma
AT quning riskpredictionandclinicalmodelbuildingforlymphnodemetastasisinpapillarythyroidmicrocarcinoma
AT shirongliang riskpredictionandclinicalmodelbuildingforlymphnodemetastasisinpapillarythyroidmicrocarcinoma
AT luzhongwu riskpredictionandclinicalmodelbuildingforlymphnodemetastasisinpapillarythyroidmicrocarcinoma
AT jiqinghai riskpredictionandclinicalmodelbuildingforlymphnodemetastasisinpapillarythyroidmicrocarcinoma
AT wuweili riskpredictionandclinicalmodelbuildingforlymphnodemetastasisinpapillarythyroidmicrocarcinoma